Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Allogeneic Cultured Keratinocytes Dermal Fibroblasts Murine Collagen-dsat

            Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: StrataGraft

            Highest Development Status: Approved Product Type: Cell and Gene therapy

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable June 15, 2021

            Details:

            StrataGraft is a bioengineered, allogeneic, "cellularized scaffold product" developed from keratinocytes grown on gelled collagen that contain dermal fibroblasts.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Centhaquine

            Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Lyfaquin

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable May 10, 2021

            Details:

            Lyfaquin® is a frontline therapy used in conjunction with the standard of care and is well-positioned to address critical unmet needs in hypovolemic shock. The Company is marketing Centhaquine Citrate, with the brand name Lyfaquin® to health care professionals in India.